MENU

language
    Group enterprise

    Group enterprise

    Guizhou Tongyuan Chinese Medicine Development Co., Ltd. is a modern, integrated, full-industry-chain health-care pharmaceutical enterprise that combines the cultivation of Chinese medicinal materials, the production of processed Chinese medicinal herbs, and wholesale distribution of pharmaceutical products.

    Guizhou Lijian Chinese Medicine Technology Co., Ltd.


    Established in April 2025 and located in the Tunzhou Industrial Park, Jianhe County, Qiandongnan Prefecture, Guizhou Province, Guizhou Lijian Chinese Medicine Technology Co., Ltd. is a core subsidiary of Guizhou Qinduo Pharmaceutical Group. The company focuses on the development of authentic Guizhou Chinese medicinal materials, establishing an integrated industrial operation model that encompasses "Seed and Seedling R&D Propagation — Standardized Cultivation — Procurement and Processing — Food Production — Bulk Storage and Trading." Our mission is to build a benchmark enterprise for regional Chinese medicinal materials.

    Core Business & Operations

    Since its inception, the company has focused on major authentic and rare Chinese medicinal materials native to Guizhou, including UncariaPolygonatumEpimediumDrynariaStemonaDrynaria fortunei, and Cibotium barometz. We have steadily advanced the construction of all links in the industrial chain:

    • Seedlings & Cultivation:
      An initial Seed and Seedling Selection and Propagation Center and Standardized Cultivation Bases have been established. This provides high-quality germplasm resources and technical support for large-scale, standardized cultivation, ensuring quality control at the source.
    • Processing & Production:
      A food production line has been set up, featuring products such as ready-to-eat PolygonatumPolygonatum herbal tea, and Dendrobium officinale powder. These products generate annual sales of approximately 30 million RMB. Sales cover South China and the Hong Kong & Macao regions, with retail channels expanded through various online platforms to meet diverse consumer health needs.
      Additionally, two processing workshops are equipped, with an annual processing capacity of 3,000 tons. The high-quality processed materials are primarily supplied to major domestic pharmaceutical enterprises, including Sinopharm Group, Tasly, Kangrentang, Yunnan Baiyao, Guangdong Wan'nianqing Pharmaceutical, and others, enjoying high market recognition.

    Future Outlook

    Moving forward, the company will continue to leverage the resource advantages of authentic Guizhou medicinal materials, promote coordinated development along the upstream and downstream of the industrial chain, and assist in the high-quality upgrading of regional characteristic Chinese medicinal industries.